Enhancing Tuberculosis Diagnosis and Treatment Monitoring: Evaluating Ki67 and HLA-DR Biomarkers Via Point-of-Care Testing and Comparative Analysis of Flow Cytometry Versus ELISA in Whole Blood Samples
Ki67 and HLA-DR are promising biomarkers for TB diagnosis and treatment monitoring. ELISA provides a reliable, cost-effective alternative to flow cytometry, supporting its use in decentralized, point-of-care settings.
Authors
- Aashutosh Asati (ORCID: https://orcid.org/0000-0003-3028-7068)
- P. P. Gupta (ORCID: https://orcid.org/0000-0002-0856-6207)
- Satyendra Kumar Mishra (ORCID: https://orcid.org/0000-0002-6390-4010)
- Mohammad Ilyas (ORCID: https://orcid.org/0000-0003-0075-9722)
- Ajay Singh (ORCID: https://orcid.org/0000-0003-2933-4058)
- Puja Singh (ORCID: https://orcid.org/0000-0002-6182-5597)
- Talha Saad
Institutions
- Bundelkhand University (IN)
- Shyam Shah Medical College (IN)
- Chirayu Medical College & Hospital (IN)
Publication Details
- Journal
- Journal of Pharmacy And Bioallied Sciences
- Published
- 2025-12-01
- DOI
- https://doi.org/10.4103/jpbs.jpbs_1074_25
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00